Skip to main content
. 2019 Aug 2;18(4):2608–2616. doi: 10.3892/etm.2019.7845

Figure 1.

Figure 1.

Effects of GSK343 on AsPC-1 and PANC-1 cell viability. (A) MTT analysis of cell viability after treatment with different concentrations of GSK343 for 48 h. (B) Cell counting kit-8 analysis of cell growth after treatment with GSK343 (IC50) for 0, 24, 48 and 72 h, **P<0.01. NC, negative control; OD, optical density.